Levocetirizine Hydrochloride Tablets

Levocetirizine hydrochloride. Chemical name: R-(-)-2-[2-[4-[(4-chlorophenyl)benzyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride Molecular weight: C21H25ClN2O3bull;2HCl

This product is white or off-white tablets.

Oral administration: Adults and children over 6 years old, 1 tablet once a day. Children aged 2-6 years old, 1/2 tablet once a day.

This product may cause adverse reactions such as headache, drowsiness, dry mouth, fatigue, weakness, abdominal pain, etc. in some patients.

1. It is contraindicated for patients with advanced renal disease whose creatinine clearance is less than 10 ml/min. 2. It is contraindicated for patients with special genetic diseases (suffering from rare galactose intolerance, primary intestinal lactase deficiency (Lapplactase) or glucose-lactose malabsorption). 3. It is contraindicated for patients who are allergic to this product and its ingredients.

Precautions for children: The safety of the drug for children under 2 years old has not been determined. Precautions for pregnancy and lactation: This product is contraindicated for pregnant and lactating women. Precautions for the elderly: The physiological functions of the elderly usually decline, so this product should be used with caution.

There is no relevant research data on the interaction between levocetirizine and other drugs, and there has been no report on the interaction between cetirizine and other drugs.

seal.

5mg*6s*3 plates

24 months

Nanyang Tianheng Pharmaceutical FACTORY of Beijing Tianheng Pharmaceutical Institute

• Founded in:

  2002-03-25

• Address:

  East Section of South Ring Road, Dengzhou City, Henan Province

• Tax NO.:

  914113817374160007

• Registered Funds:

  3 million yuan

• Website:

  Log in to view

• Email:

  Log in to view